An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer with KRAS ...
GSK (GSK) reported a study showed its drug belantamab mafodotin was able to reduce the risk of death by 42% in certain ...
That is the finding of an observational study reported at the American Society of Haematology (ASH) congress which focused on allogeneic or donor HSCTs used as a potentially curative treatment for ...
In 2022, the U.S. Congress enacted the Inflation Reduction Act (IRA), a landmark piece of legislation aimed at addressing various national priorities, including the reduction of prescription drug ...
Collaboration to evaluate monoclonal antibody as first-in-class treatment in this settingREDWOOD CITY, Calif. and HOUSTON, ...
UnitedHealth Group Incorporated faces risks from public pressure and policy changes, making it a questionable investment ...
From powerful, data-driven insights and strategic consultancy support to agenda-setting events and hiring solutions, our products and services enable everyone in higher education to make smarter, more ...
The Global Cardiac Rhythm Management Market Is Set to Expand from USD 24.7 Billion in 2024 To USD 36.7 Billion by 2034, ...
The U.S. dermal fillers market has become one of the most rapidly growing sectors within the broader cosmetic and ...
Visioneering Technologies (ASX:VTI) has announced plans to delist from the ASX, with a vote scheduled for 10 January 2025.
Integral Diagnostics (ASX:IDX) has secured clearance from the ACCC for its proposed acquisition of Capitol Health (ASX:CAJ).
Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...